98 filings
8-K
NNVC
NanoViricides Inc
5 Apr 24
Entry into a Material Definitive Agreement
5:25pm
8-K
NNVC
NanoViricides Inc
16 Feb 24
Entry into a Material Definitive Agreement
4:53pm
8-K
NNVC
NanoViricides Inc
19 Jan 24
Submission of Matters to a Vote of Security Holders
4:44pm
8-K
NNVC
NanoViricides Inc
6 Nov 23
Other Events
6:16pm
8-K
NNVC
NanoViricides Inc
1 Sep 23
Entry into a Material Definitive Agreement
4:46pm
8-K
a3fuhabzmx7rkvtlcnv
25 May 23
Other Events
4:31pm
8-K
y2nziwkkhkfgl8hu0
31 Mar 23
Entry into a Material Definitive Agreement
5:17pm
8-K
2i8u y452kq0b
13 Feb 23
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
0plm qebdxz9drkih
22 Dec 22
Submission of Matters to a Vote of Security Holders
5:11pm
8-K
v6jtxbnfhg5
11 Oct 22
Departure of Directors or Certain Officers
4:32pm
8-K
y27m04lrlz tqi
26 Nov 21
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
z3gd0
21 Sep 21
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed
11:25am
8-K
higp im6rto0t2u
15 Sep 21
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
4:36pm
8-K
1e88wqoh3s92
10 Dec 20
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
mh6xoue upf
19 Nov 20
NanoViricides Strengthens its Board of Directors with Addition of Industry Veteran Brian Zucker, CPA
4:53pm
8-K
ufw4a
4 Sep 20
NanoViricides is Developing Drugs Against SARS-CoV-2 with an Integrated Approach to Combat COVID-19, as Reported at The LD 500 Virtual Conference
4:05pm
8-K
dy3 w59e7c0zf2v
3 Aug 20
Entry into a Material Definitive Agreement
5:19pm
8-K
529pr8k8
13 Jul 20
Nanoviricides Closes on $11.5 Million Underwritten Public Offering of Common Stock
4:52pm
8-K
g4ge2la6h5
4 Jun 20
Departure of Directors or Certain Officers
4:49pm
8-K
g7m4z
22 May 20
NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering
4:10pm